Health Care & Life Sciences » Biotechnology | Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$12.11
Market Cap
$3.07 B
Shares Outstanding
49.57 M
Public Float
49.3 M

Profile

Address
6154 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.arenapharm.com
Updated 07/08/2019
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P.

Financials

View All
Created with Highcharts 5.0.14Arena Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.19 43519 43560 50860 508107 979107 97911 92011 92094 52994 52928 56928 569201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Arena Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.81 39481 39436 97036 97038 32638 32692 16392 16321 33721 33717 97017 970201320142015201620172018025k50k75k100k

Amit D. Munshi
President, Chief Executive Officer & Director
Kieran T. Gallahue
Non-Executive Director